Vaccinia Virus and Immune Checkpoint Inhibitors: A Viable Combination in Advanced RCC? Renal & Urology News, 29 May 2020 In 2019, Cancer Therapy Advisor reported on the failed phase 3 trial of the vaccinia virus (VV) pexastimogene devacirepvec (Pexa…